The telomeric region of repetitive DNA sequences at the end of chromosomes prevents end-to-end fusion of chromosome terminals and deterioration of the doublestrand free ends. Because of the ‘end-replication problem’, telomeres shorten with each round of cell division, resulting in cell senescence. The enzyme telomerase compensates for telomere shortening by elongating telomeric sequences, thereby prolonging the lifespan of the cell. Studies of articular cartilage and bone tissues have indicated that telomere shortening limits normal cell function and proliferation, while the telomere maintenance mechanisms of osteosarcoma cells facilitate escape from cell death and promote immortality. This article reviews the literature on this topic and provides an extensive discussion of the basic molecular biology and roles of telomeres and telomerase in musculoskeletal diseases such as osteoarthritis, osteoporosis and osteosarcoma. Findings to date suggest that telomeres and telomerase may become novel therapeutic targets for the diagnosis, treatment and prevention of musculoskeletal disorders.
HayflickLMoorheadPS: The serial cultivation of human diploid cell strains. Exp Cell Res1961; 25: 585–621.
2.
HayflickL: The limited in vitro lifetime of human diploid cell strains. Exp Cell Res1965; 37: 614–636.
3.
OlovnikovAM: A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol1973; 41: 181–190.
4.
HarleyCBFutcherABGreiderCW: Telomeres shorten during ageing of human fibroblasts. Nature1990; 345: 458–460.
5.
MüllerH: The remaking of chromosomes. Collecting Net (Woods Hole)1938; 13: 181–195, 198.
6.
MoyzisRKBuckinghamJMCramLS: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A1988; 85: 6622–6626.
7.
MartensUMChavezEAPoonSS: Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp Cell Res2000; 256: 291–299.
8.
AndrewsNPFujiiHGoronzyJJ: Telomeres and immunological diseases of aging. Gerontology2010; 56: 390–403.
9.
BuckinghamEMKlingelhutzAJ: The role of telomeres in the ageing of human skin. Exp Dermatol2011; 20: 297–302.
10.
ParschDBrummendorfTHRichterW: Replicative aging of human articular chondrocytes during ex vivo expansion. Arthritis Rheum2002; 46: 2911–2916.
11.
SyedFANgAC: The pathophysiology of the aging skeleton. Curr Osteoporos Rep2010; 8: 235–240.
12.
NiidaHShinkaiYHandeMP: Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA. Mol Cell Biol2000; 20: 4115–4127.
13.
ShayJWWrightWE: Ageing and cancer: the telomere and telomerase connection. Novartis Found Symp2001; 235: 116–125; discussion 125–119, 146–119.
14.
WrightWEPiatyszekMARaineyWE: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet1996; 18: 173–179.
15.
TaylorRSRamirezRDOgoshiM: Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol1996; 106: 759–765.
FerreiraMGMillerKMCooperJP: Indecent exposure: when telomeres become uncapped. Mol Cell2004; 13: 7–18.
18.
GriffithJDComeauLRosenfieldS: Mammalian telomeres end in a large duplex loop. Cell1999; 97: 503–514.
19.
de LangeT: T-loops and the origin of telomeres. Nat Rev Mol Cell Biol2004; 5: 323–329.
20.
LiuDO'ConnorMSQinJ: Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem2004; 279: 51338–51342.
21.
de LangeT: Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev2005; 19: 2100–2110.
22.
HerbigUJoblingWAChenBP: Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21CIP1, but not p16INK4a. Mol Cell2004; 14: 501–513.
23.
GreiderCWBlackburnEH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell1985; 43: 405–413.
24.
AutexierCLueNF: The structure and function of telomerase reverse transcriptase. Annu Rev Biochem2006; 75: 493–517.
25.
ZhangQKimNKFeigonJ: Architecture of human telomerase RNA. Proc Natl Acad Sci U S A2011; 108: 20325–20332.
26.
FengJFunkWDWangSS: The RNA component of human telomerase. Science1995; 269: 1236–1241.
27.
CollinsKMitchellJR: Telomerase in the human organism. Oncogene2002; 21: 564–579.
28.
LansdorpPM: Telomeres and disease. EMBO J2009; 28: 2532–2540.
29.
BlascoMA: Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet2005; 6: 611–622.
30.
WHO Scientific Group on the Burden of Musculoskeletal Conditions at the Start of the New Millennium: The burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser2003; 919: i–x, 1–218, back cover.
31.
SakalauskieneGJauniskieneD: Osteoarthritis: etiology, epidemiology, impact on the individual and society and the main principles of management. Medicina2010; 46: 790–797.
CawthonRMSmithKRO'BrienE: Association between telomere length in blood and mortality in people aged 60 years or older. Lancet2003; 361: 393–395.
34.
ZhaiGAvivAHunterDJ: Reduction of leucocyte telomere length in radiographic hand osteoarthritis: A population-based study. Ann Rheum Dis2006; 65: 1444–1448.
35.
TamayoMMosqueraARegoI: Decreased length of telomeric DNA sequences and increased numerical chromosome aberrations in human osteoarthritic chondrocytes. Mutat Res2011; 708: 50–58.
36.
HenrotinYKurzBAignerT: Oxygen and reactive oxygen species in cartilage degradation: friends or foes?Osteoarthritis Cartilage2005; 13: 643–654.
37.
HalliwellBCrossCE: Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect1994; 102 (suppl 10): 5–12.
38.
YudohKNguyenTNakamuraH: Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther2005; 7: R380–R391.
MartinJAMitchellCJKlingelhutzAJ: Effects of telomerase and viral oncogene expression on the in vitro growth of human chondrocytes. J Gerontol A Biol Sci Med Sci2002; 57: B48–B53.
43.
Piera-VelazquezSJimenezSAStokesD: Increased life span of human osteoarthritic chondrocytes by exogenous expression of telomerase. Arthritis Rheum2002; 46: 683–693.
44.
NicholsonIPGaultEAFooteCG: Human telomerase reverse transcriptase (hTERT) extends the lifespan of canine chondrocytes in vitro without inducing neoplastic transformation. Vet J2007; 174: 570–576.
45.
WattsNBLewieckiEMMillerPD: National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist. J Clin Densitom2008; 11: 473–477.
46.
KveiborgMKassemMLangdahlB: Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients. Mech Ageing Dev1999; 106: 261–271.
47.
BekaertSVan PottelberghIDe MeyerT: Telomere length versus hormonal and bone mineral status in healthy elderly men. Mech Ageing Dev2005; 126: 1115–1122.
48.
ValdesAMRichardsJBGardnerJP: Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis. Osteoporos Int2007; 18: 1203–1210.
49.
TamayoMMosqueraARegoJI: Differing patterns of peripheral blood leukocyte telomere length in rheumatologic diseases. Mutat Res2010; 683: 68–73.
50.
SandersJLCauleyJABoudreauRM: Leukocyte telomere length is not associated with BMD, osteoporosis, or fracture in older adults: results from the health, aging and body composition study. J Bone Miner Res2009; 24: 1531–1536.
51.
TangNLWooJSuenEW: The effect of telomere length, a marker of biological aging, on bone mineral density in elderly population. Osteoporos Int2010; 21: 89–97.
52.
SaeedHAbdallahBMDitzelN: Telomerase-deficient mice exhibit bone loss owing to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment. J Bone Miner Res2011; 26: 1494–1505.
53.
YudohKMatsunoHNakazawaF: Reconstituting telomerase activity using the telomerase catalytic subunit prevents the telomere shorting and replicative senescence in human osteoblasts. J Bone Miner Res2001; 16: 1453–1464.
54.
YudohKNishiokaK: Telomerized presenescent osteoblasts prevent bone mass loss in vivo. Gene Ther2004; 11: 909–915.
55.
GronthosSChenSWangCY: Telomerase accelerates osteogenesis of bone marrow stromal stem cells by upregulation of CBFA1, osterix, and osteocalcin. J Bone Miner Res2003; 18: 716–722.
56.
de JesusBBSchneebergerKVeraE: The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell2011; 10: 604–621.
57.
ShayJWBacchettiS: A survey of telomerase activity in human cancer. Eur J Cancer1997; 33: 787–791.
58.
KimNWPiatyszekMAProwseKR: Specific association of human telomerase activity with immortal cells and cancer. Science1994; 266: 2011–2015.
59.
UlanerGAHuangHYOteroJ: Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res2003; 63: 1759–1763.
Sotillo-PineiroESierrasesumagaLPatinno-GarciaA: Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients. Pediatr Res2004; 55: 231–235.
62.
YuSTChenLWangHJ: hTERT promotes the invasion of telomerase-negative tumor cells in vitro. Int J Oncol2009; 35: 329–336.
63.
MatsuoTShimoseSKuboT: Telomeres and telomerase in sarcomas. Anticancer Res2009; 29: 3833–3836.
64.
HensonJDHannayJAMcCarthySW: A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res2005; 11: 217–225.
65.
UlanerGAHoffmanAROteroJ: Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Genes Chromosomes Cancer2004; 41: 155–162.
66.
TomodaRSetoMTsumukiH: Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors. Cancer2002; 95: 1127–1133.
67.
SabahMCumminsRLeaderM: Immunohistochemical detection of hTERT protein in soft tissue sarcomas: correlation with tumor grade. Appl Immunohistochem Mol Morphol2006; 14: 198–202.
68.
PatelRMFolpeAL: Immunohistochemistry for human telomerase reverse transcriptase catalytic subunit (hTERT): A study of 143 benign and malignant soft tissue and bone tumours. Pathology2009; 41: 527–532.
69.
MirabelloLRichardsEGDuongLM: Telomere length and variation in telomere biology genes in individuals with osteosarcoma. Int J Mol Epidemiol Genet2011; 2: 19–29.
70.
ZimmermannSMartensUM: Telomeres and telomerase as targets for cancer therapy. Cell Mol Life Sci2007; 64: 906–921.
71.
TriebKThurnherDBakroevaM: Reversible downregulation of telomerase activity by hyperthermia in osteosarcoma cells. Int J Hyperthermia2000; 16: 445–448.
72.
TriebKBlahovecH: Suramin suppresses growth, alkaline-phosphatase and telomerase activity of human osteosarcoma cells in vitro. Int J Biochem Cell Biol2003; 35: 1066–1070.
73.
FujimoriJMatsuoTShimoseS: Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines. J Orthop Res2011; 29: 1707–1711.
74.
SasakiTTazawaHHaseiJ: Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas. Clin Cancer Res2011; 17: 1828–1838.
75.
LiGKawashimaHOgoseA: Efficient virotherapy for osteosarcoma by telomerase-specific oncolytic adenovirus. J Cancer Res Clin Oncol2011; 137: 1037–1051.
76.
RusinMZajkowiczAButkiewiczD: Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1. Mech Ageing Dev2009; 130: 528–537.
77.
OeseburgHde BoerRAvan GilstWH: Telomere biology in healthy aging and disease. Pflugers Arch2010; 459: 259–268.
